Increased sensitivity to cis-diamminedichloroplatinum induced apoptosis with mitochondrial DNA depletion

Cell Death and Differentiation

Volumn 5, Issue 8, 1998, Pages 694-701

  Liang, Bertrand C ^a,b   Ullyatt, Elizabeth ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

Drug resistance; Mitochondria; Tumorigenicity; U937

Indexed keywords

ADENOSINE TRIPHOSPHATE; CISPLATIN; MESSENGER RNA; MITOCHONDRIAL DNA; OLIGOMYCIN; PROTEIN BAX; PROTEIN BCL 2;

APOPTOSIS; ARTICLE; CANCER CELL; CARCINOGENICITY; DRUG SENSITIVITY; HUMAN; HUMAN CELL; PHENOTYPE; PRIORITY JOURNAL;

EID: 0031846480     PISSN: 13509047     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cdd.4400401     Document Type: Article

References (53)

1. Andrews PA and Albright KD (1992) Mitochondrial defects in cis-diamminedichlor-oplatinum (II)-resistant human ovarian carcinoma cells. Cancer Res. 52 1895-1901
2. 2: Evidence for mitochondrial involvement. Cancer Res. 54: 1497-1502
3. Biedler JL (1994) Drug resistance: Genotype versus phenotype-thirty-second G.H.A. Clowes Memorial Award Lecture Cancer Res. 54: 666-678
4. Burger AM, Kaur G, Alley MC, Supko JG, Malspeis L and Grever MR (1995) Tyrphostin AG17, [(3,5-Di-tert-buty[-4-hydroxybenzylidene)-malononitrile], inhibits cell growth by disrupting mitochondria. Cancer Res. 55:2794-2799
5. Castedo M, Macho A, Zamzani N, Hirsch T, Marchetti P, Unel J and Kroemer G (1995) Mitochondrial perturbations define lymphocytes undergoing apoptotic depletion in vivo. Eur. J. Immunol. 25: 3277-3284
6. Cavalli L, Varella-Garcia M and Liang BC (1997) Changes in tumorgenic phenotype acheived by depletion of mitochondrial DNA Cell Growth and Differentiation 8: 1189-1198
7. Chan HS, DeBoer G, Haddad G, Gallie BL and Ling V (1995) Multidrug resistance in pediatric malignacies Hematology-Oncology Clinics of North America 9:275-318
8. Chao CC (1995) Lack of elevated drug efflux in adriamycin-resistant immumoblastic B lymphoma cells with mdr1 overexpression. FEBS Letters 373:285-290
9. Chomyn A (1996) Platelet mediated transformation of human mitochondrial DNA-less cells. Methods in Enzymology. Mitochondrial Biogenesis and Genetics 246, 334-339
10. Cossarizza A, Franceschi C, Monti D, Salvioli S, Bellesia E, Rivabene R, Biondo L, Rainaldi G, Tinan Aand Malorni W (1995) Protective effect of N-acetylcysteine in tumor necrosis factor-α-induced apoptosis in U937 cells: the role of mitochondria. Exp Cell Res. 220: 232-240
11. Dabholkar M, Bostick-Bruton R and Reed E (1992) ERCC1 and ERCC2 expression in fresh human tumor tissues. Journal of the National Cancer Institute 84: 1512-1517
12. Dabholkar M, Vionnet J. Bostick-Bruton F, Yu JJ and Reed E (1994) Messenger RNA levels of XPAC and ERCC1 in ovarian cancer tissue correlate to response to platinum based chemotherapy. Journal of Clinical Investigation 94: 703-708
13. Decaudin D, Geley S, Hirsch T, Castedo M, Marchetti P and Macho A (1997) Bcl-2 and Bcl-X antagonize the mitochondriai dysfunction preceding nuclear apoptosis induced by chemotherapeutic agents. Cancer Res 57:62-67
14. Deckwerth TL and Johnson EM (1993) Temporal analysis of events associated with programmed cell death (apoptosis) of sympathetic neurons deprived of nerve growth factor. J Cell Biol. 123: 1207-1222
15. Eguchi Y, Shimizu S and Tsujimoto Y (1997) Intracelluar ATP levels determine Cell Death Fate by Apoptosis or Necrosis. Cancer Res 57: 1835-1840
16. Friesen C, Herr I, Krammer PH and Debatin K-M (1996) Involevement of the CD95 (APO-1/Fas) receptor/ligand system in drug-induced apoptosis in leukemia cells. Nature Medicine 2 574-578
17. Goldstein LJ (1995) Clinical reversal of drug resistance. Current Problems in Cancer 19: 65-124
18. Hannun YA (1997) Apoptosis and the Dilemma of Cancer Chemotherapy. Blood 89: 1845-1853
19. Heerdt BG, Houston MA and Augenlicht LH (1997) Short-chain fatty acid-initiated cell cycle arrest and apoptosis of colonic epithelial cells is linked to mitochondrial function. Cell Growth & Differentiation 8: 523-532
20. Heerdt BG, Houston MA, Rediske JJ and Augenlicht LH (1996) Steady-state levels of Mitochondrial Messenger RNA Species characterize a Predominant Pathway culminating in apotosis and shedding of HT29 Human Colon Carcinoma Cells. Cell Growth and Differentiation 7:101-106
21. Jacobson MD, Burne JF, King MP, Miyashita T, Reed JC and Raff MC (1993) Bcl-2 blocks apoptosis in cells lacking mitochondria. Nature 361: 365-369
22. Jacobson MD, Burne JF and Raff MC (1994) Programmed cell death and bcl-2 protection in the absence of a nucleus EMBO J. 13:1899-1910
23. Kerr JFR, Winterford CM and Harmon BV (1994) Apoptosis: its significance in cancer and cancer therapy Cancer 73:2013-2016
24. Kimmelman A, Ross D and Liang BC (1996) Loss of heterozygosity of chromosome 10p in human gliomas. Genomics 34 250-254
25. King MP and Attardi G (1996) Isolation of human cell lines lacking mitochondrial DNA. Methods in Enzymology:Mitochondrial Biogenesis and Genetics 264: 304-313 Academic Press, Inc
26. Kluck RM, Bossy-Wetzel E, Green DR and Newmeyer DD (1997) The release of cytochrome c from mitochondria. a primary site for bcl-2 regulation of apoptosis Science 275: 1132-1136
27. Kroemer G, Petit PX, Zamzani N, Vayssiere JL and Mignotte B (1995) The biochemistry of apoptosis. FASEB J 9: 1277-1287
28. Landowski TH, Gleason-Guzman MC and Dalton WS (1997) Selection for Drug Resistance results in Resistance to Fas-mediated Apoptosis. Blood 89:1854-1861
29. Liang BC and Hays L (1996) Mitochondnal DNA copy number alterations in human gliomas. Cancer Letters 105: 167-173
30. Liang BC, Ross DA, Greenberg HS, Metzler PS and Trent JM (1994) Evidence of allelic imbalance of chromosome 6 in glial neoplasms. Neurology 17 91-96
31. Liang BC, Ross DA and Reed E (1995) Genomic DNA copy number changes of DNA repair genes ERCC1 and ERCC2 in human gliomas. J. Neuroonc. 26: 17-23
32. Liang BC (1995) Direct isolation of variably amplified cDNAs from human tumor cell lines Int. J One 7: 611-615
33. Liang BC (1996a) Effects of hypoxia on drug resistance phenotype and genotype in human glioma cell lines. J. Neuroonc. 29: 149-155
34. Lim LC (1996) Molecular genetics of B-cell lymphomas: a review. Annals of the Academy of Medicine, Singapore 25. 37-41
35. Marchetti P, Castedo M, Susin SA, Zamzani M, Hirsch T, Macho A, Haeffner A, Hirsch F, Geuskens M and Kroemer G (1996a) Mitochondrial permeability transition is a central coordinating event of apoptosis. J Exp Med. 184: 1155-1160
36. Marchetti P, Susin SA, Decaudin D, Gamen S, Castedo M, Hirsch T, Zamzani N, Naval J, Senik A and Kroemer G (1996b) Apoptosis associated derangement of mitochondrial function in cells lacking mitochondrial DNA. Cancer Res. 56. 2033-2038
37. Miyashita T and Reed JC. (1993) BCL-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line. Blood 81. 151-157
38. Nooter K and Sonneveld P (1993) Multidrug resistance (MDR) genes in haematological malignancies Cytotechnology 12. 213-230
39. Oudard S, Poirson F, Miccoli L, Bourgeois Y, Vaxxault A and Poisson M (1995) Mitochondria-bound hexokinase as target for therapy of malignant gliomas, Int J of Caric 62. 1-7
40. Parekh H and Simpkins H (1996) Cross-resistance and collateral sensitivity io natural product drugs in cisplatin-sensiiive and -resistant rat lymphoma and human ovarian carcinoma cells. Cancer Chemotherapy and Pharmacology 37 457-462
41. Petit PX, LeCouer H, Zorn E, Dauget C, Mignotte B and Gougeon ML (1995) Alterations of mitochondrial structure and function are early events of dexamethasone-induced thymocyte apoptosis. J. Cell Biol. 130: 156-167
42. Richter C, Schweizer M, Cossarizza A and Franceschi C (1996) Control of apoptosis by the cellular ATP level. FEBS Letters 378: 107-110
43. Rodnguez C, Commes T, Robert J and Rossi JF (1993) Expression of P-gylcoprotein and anionic glutathione S-transferase genes in non-Hodgkin's lymphoma. Leukemia Res 17: 149-156
44. Schulze-Osthoff K, Walczac H, Droge W and Krammer D (1994) Cell nucleus and DNA fragmentation are not required for apoptosis. J. Cell Biol. 127: 15-20
45. Schwartz LM, Milligan CE, Bielke W and Robinson SJ (1995) Cloning Cell Death Genes. Cell Death Chapter 7: I-V Academic Press, Inc
46. Sun X, Wong JR, Song K and Chen LB (1996) Anticarcinoma activity of a novel drug, 3-ethyl-3′-methyl-thiatelluracarbocyanine iodine (Te), a tellurium-containing cyanine targeted at mitochondria. Clin. Canc Res. 2: 1335-1340
47. Sundstrom C and Nilsson K (1976) Establishment and characterization of a human histiocytic lymphoma cell line (U937). Int. J. Cane. 17: 565-577
48. Susin SA, Zamzami N. Castedo M, Daugas E, Wang H-G, Geley S, Fassy F, Reed JC and Kroemer G (1997) The Central Executioner of Apoptosis: Multiple Connections between Protease Activation and Mitochondria in Fas/APO-1/ CD95-and Ceramide-induced Apoptosis Journal Expenmental Medicine 186: 25-37
49. Warburg O, Wind F and Negelein E (1926) Uber den Stoffwechsel von Tumoren in Korper. Klin Woch 5: 829-832
50. Wilkie D, Evans IH, Egilsson V, Diala ES and Collier D (1983) Mitochondria, cell surface, and carcinogenesis. International Review of Cytology. Supplement 15, 157-189:, Academic Press, Inc
51. 1 Jones DP and Wang X (1997) Prevention of apoptosis by bcl-2: release of cytochrome c from mitochondria blocked. Science 275: 1129-1132
52. Zamzani N, Marchetti P, Castedo M, Zanin C, Vayssiere J-L, Petit PX and Kroemer G (1995) Reduction in mitochondrial potential constitutes an early irreversible step of programmed lymphocyte death in vivo J Exp Med. 181: 1661-1672
53. Zhang H, Zhang R and Liang P (1996) Differential screening of gene expression difference enriched by differential display Nucleic Acids Res. 24: 2454-2455